(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of 4.58% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.29%.
Hologic's revenue in 2026 is $4,126,500,000.On average, 20 Wall Street analysts forecast HOLX's revenue for 2026 to be $958,836,866,975, with the lowest HOLX revenue forecast at $913,294,906,355, and the highest HOLX revenue forecast at $997,681,480,445. On average, 19 Wall Street analysts forecast HOLX's revenue for 2027 to be $1,007,057,766,455, with the lowest HOLX revenue forecast at $950,353,560,585, and the highest HOLX revenue forecast at $1,051,706,747,455.
In 2028, HOLX is forecast to generate $1,053,269,461,790 in revenue, with the lowest revenue forecast at $986,742,480,100 and the highest revenue forecast at $1,117,787,239,335.